Methadone/Buprenorphine 101

Size: px
Start display at page:

Download "Methadone/Buprenorphine 101"

Transcription

1 Methadone/Buprenorphine 101 October 1, 2016 Joy Bhimji, BSP Manager, Drug Programs

2 College of Physicians and Surgeons of British Columbia 2

3 College of Physicians and Surgeons of British Columbia 3

4 Regulatory framework The College s goal is to ensure an adequate, well-trained methadone maintenance workforce in BC College of Physicians and Surgeons of British Columbia 4

5 Overview of presentation Understand the regulatory framework for methadone Identify the types of methadone authorizations Know the process to obtain an authorization Methadone Practice Assessments College of Physicians and Surgeons of British Columbia 5

6 Regulatory framework Health Canada Ministry of Health College of Physicians and Surgeons of BC College of Physicians and Surgeons of British Columbia 6

7 Regulatory framework College s role Set standards Recommendations/physician roster Provide education Not to punish or micromanage No patient registry College of Physicians and Surgeons of British Columbia 7

8 Methadone and buprenorphine maintenance is more than just a script Analgesia Suboxone OUD College of Physicians and Surgeons of British Columbia 8

9 Authorization types Methadone authorizations 1. Methadone for opioid use disorder 2. Methadone for analgesia 3. Methadone for hospitalists 4. Temporary authorizations for methadone Locum in clinic or correctional centre Hospital (patient-specific) College of Physicians and Surgeons of British Columbia 9

10 Methadone authorization for opioid use disorder Obtaining an an authorization exemption Attendance at Methadone 101 Workshop sponsored by the College Familiarization with the Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder Familiarization with the Safe Prescribing of Drugs with Potential for Misuse/Diversion document Preceptorship satisfactory to the Methadone Maintenance Program Commitment to regularly review the PharmaNet profile of your patient(s) Commitment to prescribe methadone dispensed as daily witnessed ingestion until the patient has sufficient clinical stability and is able to safely store methadone carries Commitment to discussing the availability of take-home naloxone with any patient being discharged on methadone Agreement to undertake a minimum of 12 hours of continuing medical education (CME) in addiction medicine each year Agreement to undergo regular assessments of your methadone maintenance practice College of Physicians and Surgeons of British Columbia 10

11 Obtaining an authorization Methadone authorization for analgesia Familiarization with the recommended key articles on methadone for analgesia Familiarization with the Recommendations for the Use of Methadone for Pain handbook Familiarization with the Safe Prescribing of Drugs with Potential for Misuse/Diversion document Completion of the Methadone for Pain in Palliative Care online course ( Commitment to regularly review the PharmaNet profile of your patient(s) College of Physicians and Surgeons of British Columbia 11

12 Methadone authorization for hospitalists Obtaining an an authorization exemption Attendance at Methadone 101 Workshop sponsored by the College Familiarization with the Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder Familiarization with key articles on methadone for analgesia Familiarization with the Recommendations for the Use of Methadone for Pain handbook Familiarization with the Safe Prescribing of Drugs with Potential for Misuse/Diversion document Commitment to regularly review the PharmaNet profile of your patient(s) Commitment to prescribe methadone dispensed as daily witnessed ingestion until the patient has sufficient clinical stability and is able to safely store methadone carries College of Physicians and Surgeons of British Columbia 12

13 Methadone authorization for hospitalists Obtaining an an authorization exemption Commitment to discussing the availability of take-home naloxone with any patient being discharged on methadone Understanding that this dual authorization allows you to prescribe methadone both for analgesia and opioid use disorder but agreement not to initiate methadone treatment without consultation with a physician who has a full authorization to prescribe methadone (either for analgesia or opioid use disorder, as appropriate) Understanding that your application for a federal authorization to prescribe methadone both for analgesia and opioid use disorder refers to in-hospital patients but includes the provision of appropriate discharge prescriptions Commitment to ensuring that any patient for whom you prescribe methadone in hospital has an identified community prescriber and that I will communicate with that prescriber prior to the patient's discharge College of Physicians and Surgeons of British Columbia 13

14 Temporary authorizations for methadone Valid for a maximum of 60 days (maximum two back-to-back) Allow prescriptions at a patient s current dose, or at a lower dose if clinically indicated Must have prior approval by a fully authorized physician to increase the methadone dose Not able to register (initiate) patients in the Methadone Maintenance Program Must contact the College to confirm the temporary authorization has been processed and to order prescription pad Good standing with the College Obtaining an an authorization exemption Satisfactory review of PharmaNet practitioner prescription profile College of Physicians and Surgeons of British Columbia 14

15 METHADONE PRACTICE ASSESSMENT (MPA) College of Physicians and Surgeons of British Columbia 15

16 What happens? The methadone practice assessment is a regular evaluation of methadone practice. The intention is to continually improve quality of methadone maintenance treatment in BC and make it more accessible, while maintaining patient safety and enabling successful outcomes. Assessments can be documentary or office, and assessors provide support and guidance throughout the process. Once an assessment is completed, the College welcomes feedback through the Peer Practice Assessment Evaluation. A copy of the completed MPA will be sent to you with recommendations as necessary. College of Physicians and Surgeons of British Columbia 16 16

17 Methadone practice assessments When starting out, don t wait to ask questions! We are here to support you. Within the first year, College will request charts for documentary practice assessment by medical consultant. What are we looking for? Complete workup Good documentation Use of PharmaNet Dosing Policies: UDT, missed dose, carries Discussion regarding naloxone Based on score, we will: review again when authorization is up for renewal arrange on-site assessment College of Physicians and Surgeons of British Columbia 17

18 To prepare Keep current and review the following: Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder Methadone peer practice assessment form Checklist for Methadone or Buprenorphine Maintenance Prescriber Methadone and Buprenorphine Prescribers Tool Kit Check website: Methadone Maintenance Program College of Pharmacists of BC, Professional Practice Policy #6: Policy Guide Methadone Maintenance Treatment in advance College of Physicians and Surgeons of British Columbia 18

19 Questions? Methadone Maintenance Program Phone: ext Fax: College of Physicians and Surgeons of British Columbia 19

Methadone/Buprenorphine Prescriptions

Methadone/Buprenorphine Prescriptions Methadone/Buprenorphine Prescriptions From office to pharmacy to patient Joy Bhimji BSP Methadone/Buprenorphine 101 Workshop December 10, 2016 Which prescription (Rx)? Suboxone write in DWI, carry info

More information

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone):

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone): Nurse Practitioner Change in Scope of Practice: Education and Practice Requirements for Nurse Practitioners (NPs) to Prescribe Buprenorphine-Naloxone (Suboxone) and Methadone On October 20 th, 2017, ARNNL

More information

BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 2012/2013

BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 2012/2013 BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 212/213 Office of the Provincial Health Officer With contributions by: Medical Beneficiary & Pharmaceutical Services Division & Population and

More information

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018 The Minister s Opioid Emergency Response Commission was established May 31, 2017 to support the Government of Alberta s urgent response to the opioid crisis. As part of its mandate, the Commission is responsible

More information

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Safe Prescribing of Drugs with Potential for Misuse/Diversion College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines

More information

BC Methadone Maintenance System: Performance Measures 2011/2012 Appendix A: Report Figures and Data

BC Methadone Maintenance System: Performance Measures 2011/2012 Appendix A: Report Figures and Data BC Methadone Maintenance System: Performance Measures 2011/2012 Pharmaceutical Services Division & Population and Public Health Division British Columbia Ministry of Health February 2013 You may download

More information

BC Methadone Maintenance System

BC Methadone Maintenance System BC Methadone Maintenance System Performance Measures 211/212 Office of the Provincial Health Officer With contributions by: Pharmaceutical Services Division & Population and Public Health Division British

More information

SASKATCHEWAN METHADONE PROGRAM

SASKATCHEWAN METHADONE PROGRAM College of Physicians and Surgeons of Saskatchewan SASKATCHEWAN METHADONE PROGRAM Annual Report 2014 Date submitted: 11 September, 2015 P a g e 2 Table of Contents ANNUAL REPORT 2014... 3 About the Methadone

More information

PROVINCIAL OPIOID ADDICTION TREATMENT SUPPORT PROGRAM PRECEPTORSHIP WORKBOOK FOR HOSPITAL SETTINGS

PROVINCIAL OPIOID ADDICTION TREATMENT SUPPORT PROGRAM PRECEPTORSHIP WORKBOOK FOR HOSPITAL SETTINGS PROVINCIAL OPIOID ADDICTION TREATMENT SUPPORT PROGRAM PRECEPTORSHIP WORKBOOK FOR HOSPITAL SETTINGS 11 About the British Columbia Centre on Substance Use The BC Centre on Substance Use (BCCSU) is a new

More information

College of Physicians and Surgeons of British Columbia. Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder

College of Physicians and Surgeons of British Columbia. Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder College of Physicians and Surgeons of British Columbia Methadone and Buprenorphine: Clinical Practice Guideline for Opioid Use Disorder July 2016 CONTENTS Preface... 1 Introduction... 3 1. The History

More information

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016 Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of

More information

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference Ministry of Health and Long-Term Care Presentation to the CPSO Methadone Prescribers Conference November 9, 2012 Overview Minister s Expert Working Group on Narcotic Addiction OxyNEO and OxyContin: Changes

More information

Cannabis for Medical Purposes

Cannabis for Medical Purposes College of Physicians and Surgeons of British Columbia Cannabis for Medical Purposes Preamble This document is a standard of the Board of the College of Physicians and Surgeons of British Columbia. College

More information

METHADONE PROGRAM ANNUAL REPORT 2012 AND BUSINESS PLAN 2013

METHADONE PROGRAM ANNUAL REPORT 2012 AND BUSINESS PLAN 2013 METHADONE PROGRAM ANNUAL REPORT 2012 AND BUSINESS PLAN 2013 May 2013 P a g e 2 Table of Contents ANNUAL REPORT 2012... 3 BUSINESS PLAN 2013... 6 APPENDICES A - Methadone Monthly Patient Statistics 2012...

More information

Opioid Treatment Program Reimbursement Re-bundling Proposal

Opioid Treatment Program Reimbursement Re-bundling Proposal Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders

More information

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

Responding to BC s Opioid Overdose Epidemic

Responding to BC s Opioid Overdose Epidemic Responding to BC s Opioid Overdose Epidemic Progress Update September 2017 BACKGROUND Since BC s Public Health Emergency was declared in 2016, people across the province have mobilized to immediately respond

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Continuing Education Requirements

Continuing Education Requirements Continuing Education Requirements Updated May 2015 Contents 2 Introduction Program Principles 3 Program Objective 4 Quality Assurance Requirements, including: Reporting Credits Records of Continuing Education

More information

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM April 28, 2017 Disclosure Relationship with commercial interests: None Professional roles: Addictions

More information

Methadone Maintenance Payment Program

Methadone Maintenance Payment Program MINISTRY OF HEALTH Methadone Maintenance Payment Program Review Medical Beneficiary and Pharmaceutical Services Division 1/19/2015 Version 6.4 1 Executive Summary This report was prepared for the Medical

More information

Prescribing and Dispensing Drugs

Prescribing and Dispensing Drugs STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 2014/ /2016

BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 2014/ /2016 BC OPIOID SUBSTITUTION TREATMENT SYSTEM Performance Measures 2014/2015-2015/2016 Office of the Provincial Health Officer With contributions by: Medical Beneficiary & Pharmaceutical Services Division &

More information

FREQUENTLY ASKED QUESTIONS PHARMACISTS

FREQUENTLY ASKED QUESTIONS PHARMACISTS FREQUENTLY ASKED QUESTIONS PHARMACISTS Q. Why did the College update standards for methadone maintenance treatment (MMT)? A. The College updated standards for MMT in collaboration with PharmaCare and other

More information

2018/ /21 SERVICE PLAN

2018/ /21 SERVICE PLAN Ministry of Mental Health and Addictions 2018/19 2020/21 SERVICE PLAN February 2018 For more information on the Ministry of Mental Health and Addictions contact: Ministry of Mental Health and Addictions

More information

Methadone Prescribing: Changes and Guidance

Methadone Prescribing: Changes and Guidance adone Prescribing: Changes and Guidance BC Cancer Summit Nov 24, 2018 Pippa Hawley FRCPC (Pall Med) Medical Director PSMPC Program BC Cancer Clinical Professor, UBC Dept. of Medicine Disclosures No conflicts

More information

Review of Controlled Drugs and Substances Act

Review of Controlled Drugs and Substances Act Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application)

NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application) NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application) To prescribe Methadone, NPs are subject to Federal Government s Narcotic Control Regulations

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT

DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended

More information

Controlled Substances: A survey of tools and resources required by hospital pharmacists

Controlled Substances: A survey of tools and resources required by hospital pharmacists Controlled Substances: A survey of tools and resources required by hospital pharmacists TABLE OF CONTENTS 2018. Canadian Society of Hospital Pharmacists About the survey 1 The Short and Snappy 1 What CSHP

More information

NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A

NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A NP Application for Authority to Prescribe Buprenorphine-Naloxone (Suboxone) Part A Complete each section and initial the bottom of each page. Section A: Name ARNNL NP Licensure/Registration # Phone Number

More information

Addressing the Opioid Epidemic in the Veterans Health Administration

Addressing the Opioid Epidemic in the Veterans Health Administration Addressing the Opioid Epidemic in the Veterans Health Administration Julie Gochnour, MD Governor s Working Group on Veterans, Service Members, and Their Families May 25, 2017 Overview Epidemiology of the

More information

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH 2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution

More information

Reviewing patients using opioid medicines long-term for non-cancer pain

Reviewing patients using opioid medicines long-term for non-cancer pain CLINICAL AUDIT Reviewing patients using opioid medicines long-term for non-cancer pain Valid to March 2023 bpac nz better medicin e Audit focus This audit helps primary care health professionals optimise

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

The Opioid Overdose Crisis: Role of the TB Physician

The Opioid Overdose Crisis: Role of the TB Physician The Opioid Overdose Crisis: Role of the TB Physician February 22, 2019 Dr. Patricia Daly Chief Medical Health Officer Vancouver Coastal Health Source: Health Canada BC Overdose Deaths 1992 2018 BC Overdose

More information

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control CDC Guideline for Prescribing Opioids for Chronic Pain Centers for Disease Control and Prevention National Center for Injury Prevention and Control THE EPIDEMIC Chronic Pain and Prescription Opioids 11%

More information

Methadone/ Suboxone Treatment in federal prison

Methadone/ Suboxone Treatment in federal prison INFORMATION FOR FEDERAL PRISONERS IN BRITISH COLUMBIA Methadone/ Suboxone Treatment in federal prison This booklet will explain how to qualify for Opioid Substitution Therapy (OST) in prison, how it is

More information

New regulatory requirements DPCS Regulations 2017

New regulatory requirements DPCS Regulations 2017 New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...

More information

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view

More information

Treatment Agreements Clinical Contracts. Dr. Paul A. Farnan, Dr. Johan Wouterloot Prescribers Course, Vancouver, BC, Canada October 13, 2017

Treatment Agreements Clinical Contracts. Dr. Paul A. Farnan, Dr. Johan Wouterloot Prescribers Course, Vancouver, BC, Canada October 13, 2017 Treatment Agreements Clinical Contracts Dr. Paul A. Farnan, Dr. Johan Wouterloot Prescribers Course, Vancouver, BC, Canada October 13, 2017 Faculty/presenter disclosure Presenter: Dr. Paul Farnan Relationships

More information

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good

Dear DEA. Howard A. Heit, MD, FACP, FASAM,* Edward Covington, MD, and Patricia M. Good PAIN MEDICINE Volume 5 Number 3 2004,* Edward Covington, MD, and Patricia M. Good *Georgetown University, Washington, District of Columbia; Cleveland Clinic Foundation, Cleveland, Ohio; Office of Diversion

More information

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP THA Medication Safety Summit Wesley Geminn, PharmD, BCPP Current Trends: Overdose Deaths in 2017 72,000 Or 197 per day 8 per hour National Opioid Overdose Statistics https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates

More information

User Guide for Transition to the Drug Information System

User Guide for Transition to the Drug Information System User Guide for Transition to the Drug Information System Document Revision History Date Description Version Updated By August 12, 2013 New/revised content 1.0 Lori Emery Version 1.0 Page 2 of 13 Table

More information

The Nova Scotia Take Home Naloxone Program. Amanda Hudson-Frigault, MA NS THN Coordinator

The Nova Scotia Take Home Naloxone Program. Amanda Hudson-Frigault, MA NS THN Coordinator The Nova Scotia Take Home Naloxone Program Amanda Hudson-Frigault, MA NS THN Coordinator Amanda.Hudson@nshealth.ca nsnaloxone@nshealth.ca Who are the Health Promoters in your Neighborhood? Background The

More information

FULL REGISTRATION (365-DAY RULE EXEMPT) APPLICATION FOR PATHWAY 1

FULL REGISTRATION (365-DAY RULE EXEMPT) APPLICATION FOR PATHWAY 1 THE COLLEGE OF DENTAL HYGIENISTS OF BRITISH COLUMBIA Suite 600, 3795 Carey Road Telephone: (250) 383-4101 Victoria, British Columbia, V8Z 6T8 Facsimile: (250) 383-4144 www.cdhbc.com Email: cdhbc@cdhbc.com

More information

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Dr. David Williams Chief Medical Officer of Health National opioid-related mortality data, 2016 (Health Canada) Provincial Overdose Coordinator

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

HL18.3 REPORT FOR ACTION. Toronto Overdose Action Plan: Prevention & Response SUMMARY

HL18.3 REPORT FOR ACTION. Toronto Overdose Action Plan: Prevention & Response SUMMARY HL18.3 REPORT FOR ACTION Toronto Overdose Action Plan: Prevention & Response Date: March 10, 2017 To: Board of Health From: Acting Medical Officer of Health Wards: All SUMMARY At its meeting of December

More information

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

College of Physicians and Surgeons of British Columbia. Methadone Maintenance Program: Clinical Practice Guideline. February 2014

College of Physicians and Surgeons of British Columbia. Methadone Maintenance Program: Clinical Practice Guideline. February 2014 College of Physicians and Surgeons of British Columbia Methadone Maintenance Program: Clinical Practice Guideline February 2014 Revised July 2014 Updated CONTENTS Preface... 1 Introduction... 2 1. The

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

Professional Practice Policy #66. Policy Guide. Methadone Maintenance Treatment (2013)

Professional Practice Policy #66. Policy Guide. Methadone Maintenance Treatment (2013) Professional Practice Policy #66 Policy Guide Methadone Maintenance Treatment (2013) Forward P1 Forward Opioid dependence is a health concern with implications for the individual patient as well as the

More information

Implementing change: An overview of the NSAP Peer Mentorship

Implementing change: An overview of the NSAP Peer Mentorship NSAP CQI Webinar Implementing change: An overview of the NSAP Peer Mentorship Wednesday 28 th August 2013 Peer Mentorship Don t stress your CQI, Peer Mentors will help you fly Don t stress your CQI, Book

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.32 Subject: Suboxone Drug Class Page: 1 of 7 Last Review Date: June 24, 2016 Suboxone Drug Class Description

More information

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care) Preamble This Standard establishes the standards of practice and ethical requirements of all physicians

More information

Michigan Automated Prescription System

Michigan Automated Prescription System MAPS Michigan Automated Prescription System Accuracy of Data Edits applied. Most at 95% Two full time technicians. Two part time students. Full time analyst One shared tech and PT programmer. Data uploads

More information

Recent trends in medical cannabis use in Canada

Recent trends in medical cannabis use in Canada Recent trends in medical cannabis use in Canada Paul Grootendorst Faculty of Pharmacy, University of Toronto Department of Economics, McMaster University Cannabis therapeutic effects Cannabis has been

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT Bridging the Gap: Bridging the Gaps to addiction treatment through comprehensive collaborative practice among Advanced Practice Nurses in a large urban Medical Center Dawn Williamson, RN, DNP, PMHCNS-BC,

More information

Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid)

Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid) Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid) This Q&A covers questions the Health Care Authority (HCA) received during webinars about the opioid clinical policy

More information

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the

SENATE FILE NO. SF0042. Sponsored by: Joint Judiciary Interim Committee A BILL. for. AN ACT relating to public health and safety; creating the 0 STATE OF WYOMING LSO-000 SENATE FILE NO. SF00 Opiate overdose emergency treatment. Sponsored by: Joint Judiciary Interim Committee A BILL for AN ACT relating to public health and safety; creating the

More information

Self Assessment Training. Webinar 2012, Part 1

Self Assessment Training. Webinar 2012, Part 1 Self Assessment Training Webinar 2012, Part 1 Welcome House keeping & Introductions NSAP National Overview NSAP National Overview Palliative Care Australia (PCA) PCA standards 4 th edition (2005) ensure

More information

Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers Gordon H. Smith, Esq., Executive Vice President Maine Medical Association May 3, 2016 Facing the Opioid Crisis Today Opioid

More information

NALOXONE RISK ASSESSMENT

NALOXONE RISK ASSESSMENT NALOXONE RISK ASSESSMENT Intended audience: Non-public sector organizations. Introduction: BC is currently experiencing a public health emergency related to the unprecedented increase in opioid overdoses

More information

Community Pharmacy Distribution of Naloxone

Community Pharmacy Distribution of Naloxone Community Pharmacy Distribution of Naloxone College of Pharmacists of BC BC Centre for Disease Control Harm Reduction Program Sponsored in part by the BC Ministry of Health What is Naloxone? Naloxone is

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID

More information

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement. NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau

More information

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM October 13, 2017 Disclosure Relationship with commercial interests: None Professional roles:

More information

Medicines Optimisation Strategy

Medicines Optimisation Strategy Clinical Reducing Dosing Errors with Opioid Medicines (Controlled Drug SOP): Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic

More information

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal.

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal. Six Building Blocks Self-Assessment The purpose of the self-assessment is to initiate a discussion among the opioid improvement team (or all members of your clinic) about the current state of your organization

More information

Storage, recording & disposal of Schedule 2 Controlled Drugs. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS

Storage, recording & disposal of Schedule 2 Controlled Drugs. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS Storage, recording & disposal of Schedule 2 Controlled Drugs Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS All Controlled Drugs are listed in one of the five Schedules in the Misuse of Drugs Regulations

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Triage, Assessment and Treatment Planning

Triage, Assessment and Treatment Planning Triage, Assessment and Treatment Planning Prepared by Todd Sakakibara MD, CCFP, FCFP Clinical Assistant Professor, Dept. Family Practice UBC Diplomate of the American Board of Addiction Medicine Triage

More information

Medicaid and the Opioid Crisis

Medicaid and the Opioid Crisis Medicaid and the Opioid Crisis Erica Floyd Thomas Bureau Chief of Medicaid Policy Agency for Health Care Administration Presented to: Medical Care Advisory Committee March 20, 2018 1 Florida Medicaid Covers

More information

Alberta Health Office of the Chief Medical Officer of Health. Responding to Alberta s opioid crisis Public progress report: 2

Alberta Health Office of the Chief Medical Officer of Health. Responding to Alberta s opioid crisis Public progress report: 2 Alberta Health Office of the Chief Medical Officer of Health Responding to Alberta s opioid crisis Public progress report: 2 March 31, 2017 Background The Government of Alberta, including Alberta Health

More information

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016

KASPER Quarterly Threshold Analysis Report, Second Quarter 2016 KASPER Quarterly Threshold Analysis Report, Second Quarter 26 The Kentucky All Schedule Prescription Electronic Reporting System (KASPER) Quarterly Threshold Analysis Report is produced under a Prescription

More information

Fentanyl, Opioid Overdose and Naloxone

Fentanyl, Opioid Overdose and Naloxone Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians

More information

25/04/2017. To ensure that the Rx meets CPSS standards. To provide patient-centered, individualized care. To safely dispense the patient s medication

25/04/2017. To ensure that the Rx meets CPSS standards. To provide patient-centered, individualized care. To safely dispense the patient s medication To ensure that the Rx meets CPSS standards To provide patient-centered, individualized care To safely dispense the patient s medication To assess for clinical stability and progress in treatment Kirsty

More information

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE

More information

GoToWebinar Housekeeping: Attendee participation

GoToWebinar Housekeeping: Attendee participation GoToWebinar Housekeeping: Attendee participation Your Participation Join audio: Choose Mic & Speakers to use your computer for audio. Not recommended for desktop units but works with laptops If not using

More information

Confronting the Opioid Epidemic

Confronting the Opioid Epidemic Confronting the Opioid Epidemic Appropriately Treating Pain while Stopping Abuse Scott Kennedy, MD, Chief Medical Officer, Olympic Medical Center Ian Corbridge, RN, Clinical Policy Director, WSHA June

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

A1. Does your government have a formal, written diabetes policy or strategy?

A1. Does your government have a formal, written diabetes policy or strategy? Survey of Diabetes Programs and Services in Canada Canadian Diabetes Association Diabetes Progress Report A1. Does your government have a formal, written diabetes policy or strategy? Yes. In October 2002,

More information

Balancing access, quality and prevention of diversion of OST in Europe: a comparative analysis

Balancing access, quality and prevention of diversion of OST in Europe: a comparative analysis Balancing access, quality and prevention of diversion of OST in Europe: a comparative analysis Access to OST Types of OST in France : High dose buprenorphine (HDB) (65%) Suboxone : HDB + naloxone (3%)

More information

Nurse Practitioner Practice Guideline Treatment Agreements

Nurse Practitioner Practice Guideline Treatment Agreements Nurse Practitioner Practice Guideline Treatment Agreements In November 2012, the New Classes of Practitioners Regulations (NCPR) under Canada s Controlled Drug and Substances Act (CDSA) came into force,

More information

New Guidelines for Prescribing Opioids for Chronic Pain

New Guidelines for Prescribing Opioids for Chronic Pain New Guidelines for Prescribing Opioids for Chronic Pain Andrew Lowe, Pharm.D. CAPA Meeting October 6, 2016 THE EPIDEMIC Chronic Pain and Prescription Opioids 11% of Americans experience daily (chronic)

More information

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE

GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE GUIDELINES FOR THE MANAGEMENT OF PALLIATIVE CARE PATIENTS WITH A HISTORY OF SUBSTANCE MISUSE 41.1 GENERAL PRINCIPLES The ICD 10 diagnostic criteria for dependency syndrome are listed in Table 41.1 below.

More information

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral

More information

Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada

Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada Emilie J. Gladstone, Kate Smolina, Deirdre Weymann, Kimberly Rutherford, and Steven

More information

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland Safe Prescribing and Dispensing of Controlled Drugs Joint Guidance Medical Council and Pharmaceutical Society of Ireland Purpose of this Guidance Purpose of this Guidance This resource aims to facilitate

More information

Authors: Carlo Marra, Larry Lynd, Kelly Grindrod, Pamela Joshi, Alana Isakovic

Authors: Carlo Marra, Larry Lynd, Kelly Grindrod, Pamela Joshi, Alana Isakovic AN OVERVIEW OF PHARMACY ADAPTATION SERVICES IN BRITISH COLUMBIA Authors: Carlo Marra, Larry Lynd, Kelly Grindrod, Pamela Joshi, Alana Isakovic This evaluation was completed by the Collaboration for Outcomes

More information

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary

NHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary Directorate for Health and Social Care Integration Primary Care NHS Circular: abcdefghijklmnopqrstu Dear Colleague LIST OF DRUGS SUBJECT TO PRESCRIBING TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH

More information

Auckland Methadone Service. Community Pharmacy Methadone Dispensing Manual. CADS Auckland

Auckland Methadone Service. Community Pharmacy Methadone Dispensing Manual. CADS Auckland Community Pharmacy Methadone Dispensing Manual CADS Auckland www.cads.org.nz Waitemata CADS Contact details AMS and CADS units Note: Please do not provide individual staff phone numbers to clients. Pitman

More information

Addressing the Opioid Crisis An ACH Collaboration

Addressing the Opioid Crisis An ACH Collaboration Addressing the Opioid Crisis An ACH Collaboration The purpose of this document is to offer a set of strategies that can help hospitals, health systems, and independent/group practices and Accountable Communities

More information